Lombard Odier Asset Management (Europe) LTD Abb Vie Inc. Transaction History

Lombard Odier Asset Management (Europe) LTD

$1.45 Billion
Q2 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $331,832 - $369,680	-3,154 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $1.46 Million - $1.61 Million	-14,303 Reduced 81.93%	3,154 $341,000
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $291,937 - $394,146	3,627 Added 26.23%	17,457 $1.85 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $42,481 - $56,846	579 Added 4.37%	13,830 $1.36 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $153,252 - $232,349	-2,376 Reduced 15.2%	13,251 $1.01 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $23,192 - $29,644	353 Added 2.31%	15,627 $1.14 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $58,267 - $68,943	-649 Reduced 4.08%	15,274 $1.42 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $141,143 - $189,004	-1,534 Reduced 8.79%	15,923 $1.51 Million
Q4 2017 Feb 13, 2018	SELL	$89.56 - $98.21 $95,023 - $104,200	-1,061 Reduced 5.73%	17,457 $1.69 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $1.29 Million - $1.65 Million	18,518	18,518 $1.65 Million

Others Institutions Holding ABBV

# of Institutions

3,694

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

Vanguard Group Inc Valley Forge, PA

171M
Shares

$33.2 Billion
0.57% of portfolio
Black Rock Inc. New York, NY

136M
Shares

$26.6 Billion
0.54% of portfolio
State Street Corp Boston, MA

77.8M
Shares

$15.2 Billion
0.59% of portfolio
Jpmorgan Chase & CO New York, NY

53.6M
Shares

$10.4 Billion
0.81% of portfolio
Capital International Investors Los Angeles, CA

38.6M
Shares

$7.52 Billion
1.4% of portfolio

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $344B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Europe) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Europe) LTD with notifications on news.

Account